Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 25322-68-3
Drug Levels and Effects
Summary of Use during Lactation
No published experience exists with polyethylene glycol during breastfeeding. However, the drug is very poorly absorbed from the gastrointestinal tract, so it cannot enter the breastmilk in important amounts. No special precautions are required.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Constipation) Bisacodyl, Docusate, Magnesium Hydroxide, Psyllium, Sodium Phosphate; (Irritable Bowel Syndrome) Linaclotide, Lubiprostone, Plecanatide, Psyllium, Tenapanor
References
- 1.
- Lewis JH, Weingold AB., Committee of FDA-Related Matters American College of Gastroenterology. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol. 1985;80:912–23. [PubMed: 2864852]
Substance Identification
Substance Name
Polyethylene Glycol
CAS Registry Number
25322-68-3
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Peginterferon Beta.[Drugs and Lactation Database (...]Review Peginterferon Beta.. Drugs and Lactation Database (LactMed®). 2006
- Review Peginterferon Alfa.[Drugs and Lactation Database (...]Review Peginterferon Alfa.. Drugs and Lactation Database (LactMed®). 2006
- Review Peginesatide.[Drugs and Lactation Database (...]Review Peginesatide.. Drugs and Lactation Database (LactMed®). 2006
- Review Epoetin Beta.[Drugs and Lactation Database (...]Review Epoetin Beta.. Drugs and Lactation Database (LactMed®). 2006
- Safety assessment of the substance phosphorous acid, triphenyl ester, polymer with alpha-hydro-omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)], C10-16 alkyl esters (FCM No 1076), for use in food contact materials.[EFSA J. 2021]Safety assessment of the substance phosphorous acid, triphenyl ester, polymer with alpha-hydro-omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)], C10-16 alkyl esters (FCM No 1076), for use in food contact materials.EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (EFSA CEP Panel), Lambré C, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, et al. EFSA J. 2021 Aug; 19(8):e06786. Epub 2021 Aug 6.
- Polyethylene Glycol - Drugs and Lactation Database (LactMed®)Polyethylene Glycol - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...